Almost every patient who starts a GLP-1 will titrate to a higher dose. That is not a complication — it is the protocol, designed to let your body adjust and to limit gastrointestinal side effects.
What most patients do not realise when they sign up is that the price frequently rises with them. The number in the advertisement is the number at the dose you start on, and the dose you start on is one you are expected to leave behind within a couple of months.
The Short Version
Budget from your maintenance dose, not your starting dose. On some channels the difference is more than double.
Then ask any provider one question in writing: does my quoted price hold at every dose? The answer will affect your annual cost more than anything else you compare.
What Dose-Tier Pricing Actually Looks Like
These are published manufacturer self-pay schedules, not estimates.
| Channel | Starting Dose Price | Higher Dose Price | Increase |
|---|---|---|---|
| LillyDirect — Zepbound vials | $299 (2.5 mg) | $699 (10 mg and above) | +134% |
| NovoCare — Wegovy tablets | $149 (1.5 mg) | $299 (9 mg and 25 mg) | +101% |
| Ro — tirzepatide | $299 (2.5 mg) | $449 (10–15 mg with offer) | +50% |
| Amazon One Medical — oral, cash | ~$149 | ~$299 | +101% |
| GoodRx — Wegovy tablets | $149 (1.5 / 4 mg) | $299 (9 / 25 mg) | +101% |
None of this is improper — higher doses contain more active ingredient, and pricing accordingly is standard pharmaceutical practice. The problem is purely that the advertising foregrounds the entry number, and patients budget against it.
What It Costs You Over a Year
Take a patient starting Zepbound single-dose vials through LillyDirect and titrating to 10 mg over roughly four months, then maintaining.
A Realistic Twelve-Month Model
What the advertising implies: $299 × 12 = $3,588 for the year.
What actually happens: a few months climbing the tiers, then eight months at $699 = roughly $7,000 or more.
That is a gap of over $3,400 between the number you planned around and the number you pay — for the same medication, from the same provider, following the prescribed protocol.
The same pattern applies to the oral options at a smaller absolute scale. A Wegovy tablet patient moving from 1.5 mg to the 25 mg maintenance dose studied in OASIS 4 goes from $149 to $299 a month — $1,800 more across a year than the entry price suggested.
Flat-Rate Providers Remove the Variable
A meaningful segment of the compounded market charges one price regardless of dose. The provider absorbs the higher ingredient cost at larger doses, which is why flat rates often sit slightly above the very cheapest entry prices while costing far less across a course of treatment.
| Provider | Flat Rate | Applies To | Commitment |
|---|---|---|---|
| Coreage RX | $99 all-in | Both molecules, every dose | None |
| Trimi | $125 tirzepatide | Stated to apply at any dose | Annual plan |
| Remedy Meds | $299 sema / $399 tirz | Both, flat across titration | None |
| Mochi Health | Flat at all doses | Both molecules | None |
| Fifty 410 | From $133 tirzepatide | Confirm at maintenance dose | None |
The Comparison That Actually Matters
A dose-tiered channel at $299 rising to $699 looks cheaper than a flat $299 provider — until month four.
Compare twelve months at your expected maintenance dose, not one month at the starting dose. That single change in method reverses a lot of apparent price rankings.
The Other Ways the Advertised Number Understates Your Cost
Dose escalation is the biggest one, but it is not the only mechanism.
- Two-part pricing. A membership fee buys access, medication is billed separately. GoodRx is explicit that its $39 does not include medication — your real cost at the entry oral dose is $188.
- Introductory rates. A low first month reverting to a higher ongoing rate. Zealthy advertises a $39 promotional entry against a stated typical program cost of $135 per month.
- Annual-plan pricing shown as the headline. Trimi’s $99 and $125 rates require a twelve-month commitment; third-party coverage cites $235 per month billed monthly.
- Molecule premiums. Tirzepatide typically costs $50 to $250 more per month than semaglutide at the same provider. If you may need to switch for tolerability, price both.
- Coupon dependencies. CVS’s $149 cash and $25 copay figures both depend on manufacturer coupons, subject to restrictions that commonly exclude government-insured patients.
- Shipping and supplies. Sometimes included, sometimes not. Midi includes shipping in its $164 figure; others charge separately.
How to Calculate Your Real Number
Ask what dose you are likely to maintain
Your clinician can tell you the typical maintenance range for your medication and situation. This is the dose your budget should be built around, not the one you start on.
Get the price at that dose in writing
Not the entry price. Ask specifically: what will I pay per month at this dose? A provider that cannot answer clearly is telling you something.
Add every recurring fee
Membership, program fee, per-visit charges. Multiply the monthly total by twelve.
Add shipping and supplies if separate
Syringes and needles for vials, and delivery charges. These are small individually and meaningful annually.
Check whether the rate is promotional or annual-plan
Establish the ongoing month-to-month rate after any introductory period, and whether the headline requires a commitment.
Compare that figure across providers
Twelve months at maintenance dose, all-in. This is the only comparison that reflects what you will actually spend.
The Bottom Line
The advertised price is the starting-dose price. On LillyDirect that means $299 becoming $699; on NovoCare’s tablet it means $149 becoming $299. Neither is hidden, but neither is what the marketing leads with.
Model twelve months at your maintenance dose, including every membership, visit and shipping charge. That number frequently exceeds the headline by double or more, and it is the only figure worth comparing across providers.
Flat-rate providers eliminate the variable entirely — see our flat-rate provider ranking for the ones that charge the same price at every dose.
And ask the question in writing: does my quoted price hold at every dose through maintenance? It takes one sentence and can save you thousands.
Frequently Asked Questions
Why do GLP-1 prices increase with dose?
Higher doses contain more active ingredient, and both manufacturers and compounding pharmacies price accordingly. It is standard practice rather than anything improper. The issue is that advertising foregrounds the entry price, so patients budget against a number they will not be paying for long.
How much more will I actually pay?
It depends on the channel. LillyDirect’s published schedule runs $299 at 2.5 mg to $699 at 10 mg and above — a 134% increase. NovoCare’s oral Wegovy runs $149 to $299, roughly doubling. Over a year, the difference between planning on the entry price and paying the maintenance price can exceed $3,000.
Which providers charge a flat rate?
Several compounded providers do, including Coreage RX at $99 all-in for both molecules, Remedy Meds at $299 semaglutide and $399 tirzepatide, Mochi Health at all doses, and Trimi at $125 for tirzepatide at any dose on an annual plan. Manufacturer channels generally do not.
Is a flat rate always the better deal?
Not at the starting dose — flat-rate providers often price slightly above the cheapest entry rates because they absorb higher-dose costs. Across a full course at maintenance dose, they are almost always cheaper. Compare on twelve months, not one.
What dose will I end up on?
That is a clinical question for your prescriber, and it varies by medication, tolerance and response. Ask for the typical maintenance range for your situation before you choose a provider, because it determines which pricing structure suits you.
Do the oral GLP-1s escalate too?
Yes. NovoCare prices the Wegovy tablet at $149 for 1.5 mg, $199 for 4 mg, and $299 for 9 mg and 25 mg. The 25 mg dose is the maintenance dose studied in OASIS 4, so most patients should budget around $299 rather than $149.
What is the single best question to ask a provider?
’Does my quoted price hold at every dose through my expected maintenance dose — and can you confirm that in writing?’ A clear yes is worth real money. A vague answer is worth knowing about before you pay.
⚕️ Medical Disclaimer:
This article is for informational purposes only and is not medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications with serious risks and contraindications, including a boxed warning for thyroid C-cell tumors. Only a licensed clinician who knows your medical history can determine whether any weight-management medication is appropriate for you. See our full medical disclaimer.
Disclosure:
This article is based on publicly available pricing information published by manufacturers and providers, current as of August 2026. Presidential GLP-1 may receive compensation from some providers featured on this site, which helps us provide free, independent reviews. Prices cited are as published and are subject to change, promotional windows and eligibility conditions. The twelve-month cost illustrations are estimates based on typical titration patterns and published dose-tier pricing; individual titration schedules and maintenance doses vary and are determined by your clinician. Verify current pricing directly with any provider before enrolling. Nothing here is medical advice.
Related Reading
Switching GLP-1 Providers
Changing provider without a treatment gap, and what to do if supply stops.
The Five GLP-1 Pricing Models, Compared
The one calculation that puts any two providers on equal terms.
Best Flat-Rate GLP-1 Providers
Providers whose price does not change as you titrate.
GLP-1 Provider Comparison
Every provider compared on pricing structure and what the fee includes.
Complete GLP-1 Cost Guide
Every strategy for reducing what you pay, from coupons to assistance programs.
Cheapest GLP-1 Providers
Ranked by lowest total monthly cost with quality maintained.